Our oncology specialist, currently, 16 of them, specializes in providing medical oncology services targeting all the various cancers, with special interest in breast cancer, colon cancer, lung cancer, liver, biliary and pancreatic cancers, gastro-intestinal cancers, head and neck cancers, lymphoma, leukaemia, genitourinary and gynaecological cancers, haematology malignancies and brain cancer. All our highly highly-qualified doctors, all of whom, have undergone extensive sub-specialty training in leading oncology centres around the world which include amongst others, MD Anderson Cancer Institute, Stanford University Medical Centre and Memorial Sloane Kettering Cancer Centre. Collectively, our multidisciplinary specialists come together to determine optimal choice, treatment strategies and options for our patients across a host of cancer types through tumour board meetings, leading to better outcomes and patient care.
Our Group has a patient-oriented focus and a philosophy of providing personalized, caring and consistent medical care. The high quality of medical skills possessed by our specialists allows us to handle more of the complex clinical cases. We are often called upon to render second opinions on patients and take on treatment for those who have failed prior treatments.
We are constantly updating our range of medicines and chemotherapies so as to equip our clinics with better drugs to enable our doctors to provide quality cancer treatment for our patients aimed at improved treatment efficacy and better quality of life.
The newer chemotherapies such as biological agents and targeted cancer therapies are generally associated with improved overall results and reduced – or even absent – side effects. Chemotherapy is carefully administered by our qualified nurses who have specialised training in oncology, and under the close supervision of our medical oncologists.
We provide the following chemotherapy options:
- Upfront or induction chemotherapy: This method shrinks the tumour size before definitive local treatment with surgery or radiotherapy.
- Concurrent chemo-radiation where drugs are used as radio-sensitisers to improve the effectiveness of radiotherapy:
- Adjuvant chemotherapy: Drugs are administered after surgery or radiotherapy to treat invisible micrometastases and improve the overall chances of cure.
- Curative chemotherapy: This is generally used to treat very chemo-sensitive cancers like leukemia, myeloma, lymphoma and germ cell cancers.
- High-dose chemotherapy and stem cell rescue: In this method, stem cells are extracted before high-dose chemotherapy is applied, and re-infused post-treatment to help the bone marrow recover.
- Palliative chemotherapy (for advanced cancers): For advanced cancers, this approach kills cancer cells, controls the disease and prolongs survival while striving to preserve quality of life.